These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19074869)

  • 21. BRCA1 and BRCA2 mutations in women from Shanghai China.
    Suter NM; Ray RM; Hu YW; Lin MG; Porter P; Gao DL; Zaucha RE; Iwasaki LM; Sabacan LP; Langlois MC; Thomas DB; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):181-9. PubMed ID: 14973102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population.
    Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer.
    Cavallone L; Arcand SL; Maugard CM; Nolet S; Gaboury LA; Mes-Masson AM; Ghadirian P; Provencher D; Tonin PN
    Fam Cancer; 2010 Dec; 9(4):507-17. PubMed ID: 20694749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.
    FitzGerald MG; MacDonald DJ; Krainer M; Hoover I; O'Neil E; Unsal H; Silva-Arrieto S; Finkelstein DM; Beer-Romero P; Englert C; Sgroi DC; Smith BL; Younger JW; Garber JE; Duda RB; Mayzel KA; Isselbacher KJ; Friend SH; Haber DA
    N Engl J Med; 1996 Jan; 334(3):143-9. PubMed ID: 8531968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.
    Yu KD; Di GH; Li WF; Rao NY; Fan L; Yuan WT; Hu Z; Wu J; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 May; 121(1):157-67. PubMed ID: 19728081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SULT1A1 R213H polymorphism and breast cancer risk: a meta-analysis based on 8,454 cases and 11,800 controls.
    Wang Z; Fu Y; Tang C; Lu S; Chu WM
    Breast Cancer Res Treat; 2010 Jul; 122(1):193-8. PubMed ID: 19949855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caution in generalizing known genetic risk markers for breast cancer across all ethnic/racial populations.
    Chen F; Stram DO; Le Marchand L; Monroe KR; Kolonel LN; Henderson BE; Haiman CA
    Eur J Hum Genet; 2011 Feb; 19(2):243-5. PubMed ID: 21102626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis.
    Wang J; Wang B; Bi J; Di J
    Breast Cancer Res Treat; 2011 Jul; 128(1):203-9. PubMed ID: 21188629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients.
    Gervas P; Klyuch B; Denisov E; Kiselev A; Molokov A; Pisareva L; Malinovskaya E; Choynzonov E; Cherdyntseva N
    Mol Biol Rep; 2019 Oct; 46(5):5537-5541. PubMed ID: 31273614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations of Galectin-3 Gene Polymorphisms with Risk and Prognosis of Cervical Cancer in Chinese Populations: A Case-Control Study.
    Fang SQ; Feng YM; Li M
    Oncol Res Treat; 2017; 40(9):533-539. PubMed ID: 28848207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women.
    Fejerman L; Stern MC; Ziv E; John EM; Torres-Mejia G; Hines LM; Wolff R; Wang W; Baumgartner KB; Giuliano AR; Slattery ML
    Carcinogenesis; 2013 Aug; 34(8):1787-93. PubMed ID: 23563089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer.
    Cao W; Wang X; Gao Y; Yang H; Li JC
    Anat Rec (Hoboken); 2013 Feb; 296(2):273-8. PubMed ID: 23175448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRCA1 and BRCA2 mutations in Russian familial breast cancer.
    Tereschenko IV; Basham VM; Ponder BA; Pharoah PD
    Hum Mutat; 2002 Feb; 19(2):184. PubMed ID: 11793480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer.
    Kuo WH; Lin PH; Huang AC; Chien YH; Liu TP; Lu YS; Bai LY; Sargeant AM; Lin CH; Cheng AL; Hsieh FJ; Hwu WL; Chang KJ
    J Hum Genet; 2012 Feb; 57(2):130-8. PubMed ID: 22277901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
    Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
    Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC
    Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people].
    Zhou YZ; Sun Q; Lin SQ; Wang J; Liu B; Li JX; Zhou YD; Ye J; Han H; Fang FD
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):294-8. PubMed ID: 15059511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline BRCA Mutation Rates in Latina Women Presenting for Gynecologic Oncology Care.
    Hong L; Gonzalez R; Unternaehrer J; Ioffe Y
    Gynecol Obstet Invest; 2020; 85(3):214-221. PubMed ID: 32203957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.